HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Methylphenidate in amytal-resistant mutism.

Abstract
Methylphenidate eliminated mutism in a catatonic schizophrenic after Amytal had failed. Response permitted an adequate clinical evaluation and temporary resumption of eating, self-care and sociability. This suggests that methylphenidate has a useful role in the clinical evaluation of the mute patient who fails to respond to Amytal and that 2 psychopharmacological varieties of catatonic mutism may exist.
AuthorsL H Frost
JournalActa psychiatrica Scandinavica (Acta Psychiatr Scand) Vol. 79 Issue 4 Pg. 408-10 (Apr 1989) ISSN: 0001-690X [Print] United States
PMID2735213 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Methylphenidate
  • Amobarbital
Topics
  • Adult
  • Amobarbital (therapeutic use)
  • Humans
  • Infusions, Intravenous
  • Male
  • Methylphenidate (therapeutic use)
  • Mutism (drug therapy, psychology)
  • Schizophrenia, Catatonic (drug therapy, psychology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: